These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 26260598

  • 1. Use of Fluorescence Indicators in Receptor Ligands.
    Harikumar KG, Miller LJ.
    Methods Mol Biol; 2015; 1335():115-30. PubMed ID: 26260598
    [Abstract] [Full Text] [Related]

  • 2. Use of fluorescence indicators in receptor ligands.
    Harikumar KG, Miller LJ.
    Methods Mol Biol; 2009; 552():279-91. PubMed ID: 19513657
    [Abstract] [Full Text] [Related]

  • 3. Fluorescence characteristics of hydrophobic partial agonist probes of the cholecystokinin receptor.
    Harikumar KG, Pinon DI, Miller LJ.
    Biosci Rep; 2006 Apr; 26(2):89-100. PubMed ID: 16779661
    [Abstract] [Full Text] [Related]

  • 4. Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy.
    Harikumar KG, Clain J, Pinon DI, Dong M, Miller LJ.
    J Biol Chem; 2005 Jan 14; 280(2):1044-50. PubMed ID: 15520004
    [Abstract] [Full Text] [Related]

  • 5. Environment and mobility of a series of fluorescent reporters at the amino terminus of structurally related peptide agonists and antagonists bound to the cholecystokinin receptor.
    Harikumar KG, Pinon DI, Wessels WS, Prendergast FG, Miller LJ.
    J Biol Chem; 2002 May 24; 277(21):18552-60. PubMed ID: 11893747
    [Abstract] [Full Text] [Related]

  • 6. Use of probes with fluorescence indicator distributed throughout the pharmacophore to examine the peptide agonist-binding environment of the family B G protein-coupled secretin receptor.
    Harikumar KG, Hosohata K, Pinon DI, Miller LJ.
    J Biol Chem; 2006 Feb 03; 281(5):2543-50. PubMed ID: 16319066
    [Abstract] [Full Text] [Related]

  • 7. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
    Harikumar KG, Pinon DI, Wessels WS, Dawson ES, Lybrand TP, Prendergast FG, Miller LJ.
    Mol Pharmacol; 2004 Jan 03; 65(1):28-35. PubMed ID: 14722234
    [Abstract] [Full Text] [Related]

  • 8. Fluorescence polarization screening for allosteric small molecule ligands of the cholecystokinin receptor.
    Harikumar KG, Cawston EE, Miller LJ.
    Assay Drug Dev Technol; 2011 Aug 03; 9(4):394-402. PubMed ID: 21395402
    [Abstract] [Full Text] [Related]

  • 9. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
    Albizu L, Teppaz G, Seyer R, Bazin H, Ansanay H, Manning M, Mouillac B, Durroux T.
    J Med Chem; 2007 Oct 04; 50(20):4976-85. PubMed ID: 17850055
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Insights into the molecular basis of ligand binding by the cholecystokinin receptor.
    Miller LJ, Ding XQ.
    Pancreatology; 2001 Oct 04; 1(4):336-42. PubMed ID: 12120212
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Steady-state fluorescence polarization/anisotropy for the study of protein interactions.
    James NG, Jameson DM.
    Methods Mol Biol; 2014 Oct 04; 1076():29-42. PubMed ID: 24108621
    [Abstract] [Full Text] [Related]

  • 14. Fluorescence resonance energy transfer analysis of the antagonist- and partial agonist-occupied states of the cholecystokinin receptor.
    Harikumar KG, Miller LJ.
    J Biol Chem; 2005 May 13; 280(19):18631-5. PubMed ID: 15757907
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Probing the binding domain of the NK2 receptor with fluorescent ligands: evidence that heptapeptide agonists and antagonists bind differently.
    Turcatti G, Vogel H, Chollet A.
    Biochemistry; 1995 Mar 28; 34(12):3972-80. PubMed ID: 7696262
    [Abstract] [Full Text] [Related]

  • 17. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
    Hadac EM, Ji Z, Pinon DI, Henne RM, Lybrand TP, Miller LJ.
    J Med Chem; 1999 Jun 17; 42(12):2105-11. PubMed ID: 10377216
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fluorescence techniques in analysis of protein-ligand interactions.
    Mocz G, Ross JA.
    Methods Mol Biol; 2013 Jun 17; 1008():169-210. PubMed ID: 23729253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.